Microscopy & Microanalysis 2019 Presentation
6th August 2019
EAG Laboratories presented “Industrial Applications of Electron Microscopy: A Shared Laboratory Perspective” at M&M 2019
MD&M West 2025
February 4-6, 2025
We are excited to announce Eurofins EAG Laboratories will exhibit and present at MD&M West in Anaheim February 4-6, 2025, in booth number 2899.
Dr. Philip Ferko, Senior Scientist with EAG, will present in the MD&M West Center Stage at 12pm on February 4.
Presentation Title: Regulatory Update: Game-Changing FDA Guidance for Part 18 Studies
Abstract: Significant changes in the FDA interpretation of chemical characterization under ISO 10993-18 are occurring. In 2024 the FDA released the “Chemicals List for Analytical Performance” and draft guidance “Chemical Analysis for Biocompatibility Assessment of Medical Devices”. The FDA also held a Public Workshop discussing the “Accreditation Scheme for Conformity Assessment and Use of Chemical Analysis to Support Biocompatibility of Medical Devices”. Clearly, the FDA is defining expectations of the Chemical Characterization programs, and the analytical testing labs must adapt to continue producing effective chemical characterization reports. This talk will discuss key changes and relevant questions to ask any analytical laboratory prior to performing chemical characterization work.
View more information about Dr. Ferko’s presentation or contact us to learn more about medical device testing solutions.
We hope to see you there!
More content you might like...
MicroXRD: Small Area Analysis of Single Grains of Sand
Microdiffraction can be used to identify crystalline inclusions in glass, look at film texture in a test pad on an integrated circuit, identify a single particle found in an air filter, or to identify the phosphor used in an LED.
Failure Analysis in Aerospace Advancement
In the aerospace industry, electronics are subjected to extreme environmental variables. EAG’s failure analysis group can help solve potential problems that may arise.
The Conspicuous Case of the Missing T0 in ISO 10993-5 Cytotoxicity Testing
In the world of medical device safety testing, ISO 10993-5 plays a crucial role. A key aspect of this, which is sometimes overlooked in certain studies, is the T0 time point, or time zero.
Component Product Qualification Webinar
In this webinar we introduce Microelectronic Component Product Qualification to understand and consider component reliability.
Next Steps After Receiving a Cytotoxic Result
It can be alarming when a product with known components and extensive planning receives a cytotoxic result. Even if the sample was designed with materials marketed to be biocompatible, minor chemical reactions—from production of the raw materials to the packaging or storage of the product—can introduce cytotoxic contaminants.